Yüklüyor......

Monoamine oxidase-B (MAO-B) inhibitors: implications for disease-modification in Parkinson’s disease

There is a substantial amount of evidence from experimental parkinsonian models to show the neuroprotective effects of monoamine oxidase-B (MAOB) inhibitors. They have been studied for their potential disease-modifying effects in Parkinson’s disease (PD) for over 20 years in various clinical trials....

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Teo, Kay Cheong, Ho, Shu-Leong
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: BioMed Central 2013
Konular:
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC3847108/
https://ncbi.nlm.nih.gov/pubmed/24011391
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/2047-9158-2-19
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!